A recent study underscored the clinical importance of early identification of Rh-negative women, to enhance lowering of the risks of Rhesus isoimmunization for both mothers and newborns in this high-risk situation.
According to this study carried out by researchers from the University of Nairobi titled; Burden of Rhesus isoimmunization and pregnancy outcomes: a cross-sectional study conducted at Kenyatta National Hospital, Kenya, rhesus isoimmunization occurs in Rh-negative pregnancies and can cause maternal and fetal complications.
Rhesus isoimmunization, also known as Rh incompatibility occurs when an RhD-negative mother is exposed to RhD-positive fetal red blood cells, leading to the production of maternal anti-D antibodies.
Rh incompatibility has adverse effects on both mother and child if it has not been identified early and managed. Consequences on the unborn child includes destruction of fetal red blood cells which in turn results in hemolytic disease of the fetus and newborn.
The clinical manifestations of Rhesus isoimmunization ranges from mild jaundice and anemia to hydrops fetalis, stillbirth, and neonatal death.
According to this study, isoimmunized women experienced significantly higher rates of adverse maternal and fetal outcomes, including miscarriages, hydrops fetalis, intrauterine fetal demise, low birth weight and increased NICU admissions compared to non-isoimmunized women.
The prevalence of RhD-negative blood varies by population, with sub-Saharan African populations recording the lowest cases globally. In Kenya, the prevalence has been reported at approximately 3.9% according to this study.
The study suggested taking of regular preventative measures for example, routine antenatal anti-D prophylaxis, and enhanced fetal surveillance to reduce sensitization of Rh incompatibility and improve maternal and neonatal outcomes.
Documenting of a partner’s blood group and prior pregnancy history, was also encouraged for risk assessment and management planning.
- Log in to post comments
